Description

Lenvatinib Capsules 10 mg – Multikinase Inhibitor for Targeted Cancer Therapy

Lenvatinib 10 mg Capsules are an oral anti-cancer medication used for treating advanced or metastatic cancers, including differentiated thyroid cancer (DTC), renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). Acting as a multi-kinase inhibitor, Lenvatinib selectively blocks multiple enzymes known as tyrosine kinases that fuel tumor growth and angiogenesis.

This 10 mg strength is frequently used as a standalone dose or as part of a combination regimen to achieve patient-specific dosages such as 14 mg or 18 mg. It may also be combined with immune checkpoint inhibitors like pembrolizumab for advanced efficacy in liver and kidney cancers.

Key Features

• Generic Name: Lenvatinib Mesylate
• Strength: 10 mg per capsule
• Dosage Form: Oral capsule
• Brand Equivalent: Lenvima
• Drug Class: Tyrosine Kinase Inhibitor (TKI)
• Prescription Required: Yes
• Manufactured Under: GMP and USFDA-compliant pharmaceutical facilities
• Typical Use: Used alone or in combination with other anti-cancer drugs

Therapeutic Uses

Lenvatinib 10 mg is prescribed to treat:

• Advanced Differentiated Thyroid Cancer (DTC) – especially RAI-refractory
• Renal Cell Carcinoma (RCC) – monotherapy or with pembrolizumab
• Hepatocellular Carcinoma (HCC) – unresectable liver cancer
• Certain off-label uses may include endometrial, lung, or other solid tumors under clinical guidance

Mechanism of Action

Lenvatinib 10 mg inhibits multiple tyrosine kinase receptors including:

• VEGF receptors 1–3
• FGFR 1–4
• PDGFRα
• RET
• KIT

By blocking these receptors, Lenvatinib restricts blood flow to tumors and interferes with signaling necessary for cancer cell survival and spread, leading to increased tumor control rates and delayed progression.

Dosage and Administration

• Usual Dosage: Varies from patient to patient; 10 mg may be used individually or in combination with other strengths (e.g., 10 mg + 4 mg for 14 mg daily)
• Route: Oral
• Frequency: Once daily
• Administration: Swallow the capsule whole with water at the same time each day
• Food: May be taken with or without food
• Storage: Store below 30°C in a dry place away from light and moisture

Note: Always follow your oncologist’s prescribed dose. Do not adjust your dose without medical supervision.

Precautions and Warnings

• Not recommended during pregnancy or breastfeeding
• May lead to increased blood pressure—routine monitoring required
• Avoid use if recent surgery has not fully healed—can impair wound healing
• Risk of proteinuria and renal impairment
• May affect liver function—regular blood tests are recommended
• Use with caution in patients with a history of heart arrhythmias or bleeding

Possible Side Effects

The side effects of Lenvatinib Capsules 10 mg often depend on the individual’s health condition, dosage, and treatment response.

Common side effects:

• Elevated blood pressure
• Loss of appetite
• Diarrhea or nausea
• Weight loss
• Fatigue
• Joint or muscle pain
• Mouth sores
• Skin rash or hand-foot syndrome

Serious side effects:

• Liver dysfunction or failure
• Cardiac complications
• Kidney failure
• Severe bleeding or blood clots
• Gastrointestinal perforation
• Infection

Seek medical attention if you experience symptoms like chest pain, unusual swelling, fainting, or shortness of breath.

Why Purchase Lenvatinib 10 mg from Us?

• Supplied by verified pharmaceutical manufacturers
• Quality-assured and licensed for global distribution
• Affordable pricing and discounts on bulk orders
• Secure, encrypted checkout and customer data protection
• Discrete worldwide shipping with full tracking support
• Support team available for product and prescription inquiries

Worldwide Shipping Coverage

We ship Lenvatinib 10 mg to several countries, including:

• United States
• United Kingdom
• United Arab Emirates
• Australia
• Canada
• Singapore
• South Africa
• Germany
• New Zealand
• Saudi Arabia and more

Delivery options include express courier, standard shipping, and doorstep delivery subject to local customs regulations.

Frequently Asked Questions (FAQs)

1. What is Lenvatinib 10 mg used for?

Lenvatinib 10 mg is used to treat thyroid, kidney, and liver cancers that are advanced or metastatic. It works by blocking tumor growth signals.

2. Is a prescription required for Lenvatinib?

Yes, Lenvatinib is a potent targeted therapy that requires a prescription and careful monitoring by a healthcare provider.

3. Can I take it with other cancer medications?

Yes, it is often used alongside other treatments such as pembrolizumab. Your oncologist will supervise any combination therapy.

4. How long should I take Lenvatinib?

As long as it remains effective and well-tolerated. Your doctor will evaluate based on disease progression, side effects, and tumor response.

5. Can Lenvatinib be taken with food?

Yes. You can take it with or without food. What matters most is taking it consistently at the same time each day.

6. Are dose adjustments common?

Yes. If side effects are intolerable, doctors may reduce from 10 mg daily to a lower dose or alternate dosage schedules.

7. What are the signs I should stop taking Lenvatinib?

Persistent mouth sores, chest pain, severe diarrhea, or shortness of breath require immediate consultation with your doctor. Treatment may need to be paused.

8. Can Lenvatinib interact with other medications?

Yes, especially with blood pressure medicines, anticoagulants, or strong CYP3A inhibitors. Always inform your doctor about your current medications.

9. Should elderly patients take a lower dose?

Possibly. Age-related organ function changes may require dose adjustments. Your doctor will determine the optimal dose for elderly patients.

10. Is Lenvatinib available as a generic?

Yes. While Lenvima is the brand, Lenvatinib Mesylate is available as a generic version in some countries, offering cost-effective treatment options.